The Weekly Bioanalysis - An Official Podcast of KCAS
"The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every month, KCAS will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they've learned about the Bioanalytical world the past couple of weeks.
"The Weekly Bioanalysis" is brought to you by KCAS.KCAS is a progressive growing contract research organization of well over 200 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA and Milan, Italy, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.
Episodes
94 episodes
Conference Season 2025: US, APAC, and European Bioanalysis Trade Shows
In this episode, hosts Dom and John welcome Jason Hannah, Director of Marketing at KCAS Bio, to discuss the company’s strategy for navigating the 2025 global conference season. With major events like AAPS PharmSci 360 in the U.S. and the Europe...
•
Season 3
•
Episode 16
•
1:13:08
Collaborating with Smaller, Scientifically-Driven Partners to Accelerate Drug Development (w/ Special Guest)
During episode #93 of The Weekly Bioanalysis, John and Dom welcome guest Chris Crean, founder/CEO of Xyzagen, who reflects on three decades in drug development and how the field has shifted from small molecules to today’s complex biolo...
•
Season 3
•
Episode 15
•
1:29:06
GLP-1 Agonists – the Current State of Play and What’s Next (w/ Special Guest)
During episode #92 of The Weekly Bioanalysis, our hosts, John and Dom, dive into GLP-1 receptor agonists—originally developed for type 2 diabetes—and how their mechanisms (stimulating insulin, slowing gastric emptying, and reducing glu...
•
Season 3
•
Episode 14
•
1:47:16
The “Grey Areas” of Bioanalysis: Drug Discovery, Biomarkers, Tissues & Technologies
In episode #91 of The Weekly Bioanalysis, John and Dom return to a two-person format to tackle the "gray areas" of bioanalysis, focusing on drug discovery, biomarkers, tissues, and emerging technologies. They discuss how traditional PK...
•
Season 3
•
Episode 13
•
1:25:27
Balancing Growth with Employee Experience, Part 2 - Special Guests, Maria Nelson & Julie Deane
In this episode of “The Weekly Bioanalysis” podcast, our hosts, Dominic Warrino and John Perkins, sit down with two key leaders shaping the company’s future — Maria Nelson, Chief Financial Officer, and Julie Deane, Chief People Officer — to dis...
•
Season 3
•
Episode 12
•
1:36:58
Balancing Growth with Employee Experience, Part 1 - Special Guest, Jeff Goddard
In Episode 89 of The Weekly Bioanalysis, hosts Dominic Warrino and John Perkins engage in a compelling conversation with special guest, Jeff Goddard, Senior Vice President of Corporate Development at KCAS Bio. The three delve into KCAS...
•
Season 3
•
Episode 11
•
1:36:52
Reflections on WRIB 2025 in New Orleans - With ALL the Guests!!
In Episode 88 of The Weekly Bioanalysis, hosts Dominic Warrino and John Perkins present a special WRIB 2025 recap featuring several KCAS Bio scientists who share firsthand insights from their presentations at the major bioanalytical co...
•
Season 3
•
Episode 10
•
1:13:07
Evolution of SCIEX’s Partnership with Pharma in Drug Discovery & Development
In episode 87 of The Weekly Bioanalysis podcast, John Perkins and Dawn Dufield preview the upcoming WRIB conference, where KCAS Bio and Sciex will both have strong representation through scientific presentations, panels, and business d...
•
Season 3
•
Episode 9
•
50:26
Immunogenicity Discussion w/ Special Guest Cheikh Kane – What is a Lean ADA?
During episode 86 of KCAS Bio's "The Weekly Bioanalysis" podcast, our hosts Dom and John are joined by Dr Cheikh Kane, the Vice President of Biopharma Services at KCAS Bio, to discuss immunogenicity. They first define Immunogenicity; what it is...
•
Season 3
•
Episode 8
•
1:17:16
Patient-Centric Sampling: Beyond the Clinic and What it Means for Bioanalysis
Dom and John, the hosts of “The Weekly Bioanalysis”, recently returned from EBF in Barcelona where there was a session on Patient-centric Microsampling, which both of them founnd fascinating. This inspired both of them to decide it was high tim...
•
Season 3
•
Episode 7
•
1:35:35
Small Molecule LC-MS Development and Evolving Approach to ADC Payloads
In episode 84 of “The Weekly Bioanalysis”, our special guest, Bryan Parmentier, joins Dom and John to discuss his background and current role at KCAS Bio, offering insights into the field of small molecule method development. He delves into the...
•
Season 3
•
Episode 6
•
1:32:24
Recap of the European Bioanalysis Forum Open Symposium
The 2024 tradeshow and conference season is finally coming to a close for the pharmaceutical and biotech industry, and our road-weary traveling hosts, Dom and John have returned from their final event, the 2024 European Bioanalysis Forum (EBF) ...
•
Season 3
•
Episode 5
•
1:17:51
Conference Season 2024: KCAS Bio’s Upcoming Exhibitions & Presentations
It’s conference season! This is a busy, busy time of the year for the entire industry, when everyone comes together from around the world to share, listen and discuss the changes and advancements taking place in the business and science of the ...
•
Season 3
•
Episode 4
•
1:32:03
GLP-1 Analogue Bioanalysis: The Value of Complimentary Technologies
After such a great response to our recent episode on the topic, our hosts, Dom and John, revisit the topic of GLP-1 Analogue development and the role bioanalysis plays in this relatively new and popular topic. In the words of John, “Everyone el...
•
Season 3
•
Episode 3
•
1:09:35
The Rapid Evolution of PCR Assays with Special Guest, Carrie Vyhlidal
Our hosts, Dom and John, are excited to welcome special guest, Carrie Vyhlidal, to discuss the topic of the 80th episode of “The Weekly Bioanalysis” podcast – The Rapid Evolution of PCR Assays. PCR (or Polymerase Chain Reaction) is like a copyi...
•
Season 3
•
Episode 2
•
1:22:46
One & Done Therapies: The Landscape of Gene Therapy for Conditions
The most recent episode of "The Weekly Bioanalysis" podcast is all about genes today! The topic was originally inspired by an article entitled "The Coming of Age of One-and-Done Therapies" which jumped out to both of our hosts, Dom and John, an...
•
Season 3
•
Episode 1
•
1:20:09
Offering Global Services: Latest News from Lyon and Melbourne
Dom has been globe-trotting lately, and he has come back to report in on his adventures with John, as they discuss our global services here at KCAS Bio. They talk about the updates and the latest news from Lyon and the rollout of our collaborat...
•
Season 2
•
Episode 26
•
1:22:04
Non-GLP Studies from Early PK to Readiness for GLP Tox Studies
Dom and John welcome special guests, Habibi Goudarzi and Rochelle Burke to episode #77 of "The Weekly Bioanalysis", where they discuss the progression of bioanalytical needs for non-GLP Studies, from Early PK to readiness for GLP Tox Studies. T...
•
Season 2
•
Episode 25
•
1:30:42
GLP-1 Analogues: Blockbuster Drugs - Applications & Challenges
For episode #76 of "The Weekly Bioanalysis", Dom and John talk about the popular topic of GLP-1 Analogues - these series of recent blockbuster drugs with multiple applications, as well as some of their bioanalytical challenges. First, the guys ...
•
Season 2
•
Episode 24
•
1:25:52
Rebranding KCAS Bio: Next Steps to an Integrated Future
CEO of KCAS Bio, John Bucksath, joins Dom and John for a special 75th episode of “The Weekly Bioanalysis” podcast, and he is absolutely delighted to use the special episode to talk about the recent rebrand of KCAS to KCAS Bio! Mr Bucksath and o...
•
Season 2
•
Episode 23
•
1:03:05
Addressing the Needs of Rare Diseases: Challenges & Trends
During this episode of “The Weekly Bioanalysis”, Dom and John talk about addressing the needs of rare diseases - some challenges and industry trends they’ve watched take place, and they are joined by guest, Lindsay Rutherford, who has her own p...
•
Season 2
•
Episode 22
•
1:13:14
The Parallel Evolution of the Bioanalytical Industry and KCAS
To kick off the first episode of “The Weekly Bioanalysis” in 2024, Dom and John unveil some fun new things happening at KCAS, by talking about the parallel evolution of the bioanalytical industry and KCAS. Our hosts go way back – almost to “squ...
•
Season 2
•
Episode 21
•
1:10:40
Introduction to Scientific Advisor Team and Recap of 2023
For the final episode of “The Weekly Bioanalysis” in 2023, Dom and John invited KCAS’s scientific advisory team to join them, as we thought that as we are coming to the end of the year, it might be a good opportunity to introduce a few members ...
•
Season 2
•
Episode 20
•
1:16:54
Drug Development and Where Bioanalytical Fits In
Dom and John have been doing this for a long time (for over 70 episodes now, to be exact), but they felt it might be a good idea to jump back to the very beginning and discuss the overarching concept of the Drug Development process and where it...
•
Season 2
•
Episode 19
•
1:17:50
Looking Forward to the 2023 Autumn Conference Season
It is that time of year once again... the Fall Conference Season! Every industry has its own set of important trade shows and meetings, but for the Pharma, biotech and bioanalytical industries, these conferences are an opportunity for the plane...
•
Season 2
•
Episode 18
•
1:08:46